Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden, BMJ, vol.315, issue.7115, pp.1060-1064, 1997. ,
DOI : 10.1136/bmj.315.7115.1060
Diagnosis of Influenza in the Community, Archives of Internal Medicine, vol.161, issue.17, pp.2116-2138, 2001. ,
DOI : 10.1001/archinte.161.17.2116
Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996, J Clin Microbiol, vol.35, issue.8, pp.2076-82, 1997. ,
Combined clinical and virological surveillance of influenza in winters of 1992 and 1993-4, BMJ, vol.311, issue.7000, pp.290-291, 1995. ,
DOI : 10.1136/bmj.311.7000.290
Medical Practice-based Influenza Surveillance: Viral Prevalence and Assessment of Morbidity, American Journal of Epidemiology, vol.141, issue.6, pp.502-508, 1995. ,
DOI : 10.1093/oxfordjournals.aje.a117464
Evaluation of Clinical Case Definitions of Influenza: Detailed Investigation of Patients During the 1995???1996 Epidemic in France, Clinical Infectious Diseases, vol.28, issue.2, pp.283-90, 1999. ,
DOI : 10.1086/515117
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections, The Journal of Infectious Diseases, vol.180, issue.2, pp.254-61, 1999. ,
DOI : 10.1086/314904
Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections, New England Journal of Medicine, vol.337, issue.13, pp.874-80, 1997. ,
DOI : 10.1056/NEJM199709253371302
Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group [published errata appear in, Lancet Lancet, vol.353353, issue.3529144, pp.1877-81, 1998. ,
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza, JAMA, vol.283, issue.8, pp.1016-1040, 2000. ,
DOI : 10.1001/jama.283.8.1016
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, The Lancet, vol.355, issue.9218, pp.1845-5027, 2000. ,
DOI : 10.1016/S0140-6736(00)02288-1
Rapid Antiviral Effect of Inhaled Zanamivir in the Treatment of Naturally Occurring Influenza in Otherwise Healthy Adults, The Journal of Infectious Diseases, vol.181, issue.4, pp.1471-1475, 2000. ,
DOI : 10.1086/315392
Population estimates of persons presenting to general practitioners with influenza-like illness, 1987???96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands, Epidemiology and Infection, vol.124, issue.2, pp.245-53, 2000. ,
DOI : 10.1017/S0950268899003660
Influenza Burden of Illness, Archives of Internal Medicine, vol.162, issue.16, pp.1842-1850, 1998. ,
DOI : 10.1001/archinte.162.16.1842
Drug Therapy: Prevention and Treatment of Influenza, N Engl J Med, vol.343, issue.24, pp.1778-1787, 2000. ,
The Efficacy of Influenza Vaccine in Elderly Persons, Annals of Internal Medicine, vol.123, issue.7, pp.518-545, 1995. ,
DOI : 10.7326/0003-4819-123-7-199510010-00008
Socioeconomics of Influenza and Influenza Vaccination in Europe, PharmacoEconomics, vol.9, issue.Supplement 3, pp.75-83, 1996. ,
DOI : 10.2165/00019053-199600093-00017
Influenza vaccination: cost-effective health care for the older adult?, J Qual Clin Pract, vol.17, issue.1, pp.3-11, 1997. ,
Influenza Vaccination in 29 Countries, PharmacoEconomics, vol.16, issue.Supplement 1, pp.47-54, 1999. ,
DOI : 10.2165/00019053-199916001-00007
Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients, Archives of Internal Medicine, vol.161, issue.2, pp.212-219, 2001. ,
DOI : 10.1001/archinte.161.2.212
Current Strategies for Management of Influenza in the Elderly Population, Clinical Infectious Diseases, vol.35, issue.6, pp.729-766, 2002. ,
DOI : 10.1086/341246
Neuraminidase inhibitors for preventing and treating influenza in healthy adults, Cochrane Database Syst Rev, vol.2, 2000. ,
Amantadine and rimantadine for preventing and treating influenza A in adults, Cochrane Database Syst Rev, vol.2, 2000. ,
Inhaled Zanamivir for the Prevention of Influenza in Families, New England Journal of Medicine, vol.343, issue.18, pp.1282-1289, 2000. ,
DOI : 10.1056/NEJM200011023431801
Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.285, issue.6, pp.748-54, 2001. ,
DOI : 10.1001/jama.285.6.748
* showcase of economic evaluation of NA-inhibitors 29 Economic evaluation of strategies for the control and management of influenza in Europe, Vaccine, vol.201920, pp.2562-78, 2002. ,
The Effectiveness of Vaccination against Influenza in Healthy, Working Adults, New England Journal of Medicine, vol.333, issue.14, pp.889-93, 1995. ,
DOI : 10.1056/NEJM199510053331401
Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults, Vaccine, vol.17, pp.67-73, 1999. ,
DOI : 10.1016/S0264-410X(99)00110-3
Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults, JAMA, vol.284, issue.13, pp.1655-63, 2000. ,
DOI : 10.1001/jama.284.13.1655
Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, Archives of Internal Medicine, vol.161, issue.5, pp.749-59, 2001. ,
DOI : 10.1001/archinte.161.5.749
Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, Annals of Internal Medicine, vol.137, issue.4, pp.225-256, 2002. ,
DOI : 10.7326/0003-4819-137-4-200208200-00005
Influenza virus neuraminidase inhibitors, The Lancet, vol.355, issue.9206, pp.827-862, 2000. ,
DOI : 10.1016/S0140-6736(99)11433-8
Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, vol.45, issue.4, pp.1162-729, 2001. ,
DOI : 10.1128/AAC.45.4.1162-1167.2001
Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, vol.45, issue.10, pp.2723-2755, 2001. ,
DOI : 10.1128/AAC.45.10.2723-2732.2001
Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants, Antimicrobial Agents and Chemotherapy, vol.45, issue.12, pp.3403-3411, 2001. ,
DOI : 10.1128/AAC.45.12.3403-3408.2001
Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors, Antiviral Research, vol.54, issue.3, pp.143-150, 2002. ,
DOI : 10.1016/S0166-3542(01)00219-4
Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation, Health Technology Assessment, vol.6, issue.9, pp.1-87, 2002. ,
DOI : 10.3310/hta6090
Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza, JAMA, vol.282, issue.13, pp.1240-1246, 1999. ,
DOI : 10.1001/jama.282.13.1240
Respiratory Distress Associated with Zanamivir, New England Journal of Medicine, vol.342, issue.9, pp.661-663, 2000. ,
DOI : 10.1056/NEJM200003023420914
Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled, BMJ, vol.322, issue.7286, pp.577-586, 2001. ,
DOI : 10.1136/bmj.322.7286.577
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, vol.53, issue.1, pp.47-61, 2002. ,
DOI : 10.1016/S0166-3542(01)00192-9
Searching literature databases for health care economic evaluations: how systematic can we afford to be?, Med Care, vol.40, issue.5, pp.387-94, 2002. ,
Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia, PharmacoEconomics, vol.34, issue.14, pp.611-631, 2000. ,
DOI : 10.2165/00019053-200017060-00007
Economic evaluation of zanamivir for the treatment of influenza. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2001. ,
Cost???Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, vol.33, issue.11, pp.1879-85, 2001. ,
DOI : 10.1086/324491
Cost-effectiveness of newer treatment strategies for influenza, The American Journal of Medicine, vol.113, issue.4, pp.300-307, 2002. ,
DOI : 10.1016/S0002-9343(02)01222-6
Rapid flu test and neuraminidase inhibitors in healthy adults : a cost-benefit analysis. In: Options for the control of influenza IV, ADME Osterhaus et al, 2000. ,
Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes, Am J Manag Care, vol.8, issue.3, pp.221-228, 2002. ,
Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults, Archives of Internal Medicine, vol.160, issue.21, pp.3234-3274, 2000. ,
DOI : 10.1001/archinte.160.21.3234
Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza, PharmacoEconomics, vol.295, issue.2, pp.187-95, 2000. ,
DOI : 10.2165/00019053-200017020-00007
Methods for the Economic Evaluation of Health Care Programmes, 1997. ,
very well developed text on the willingness-to-pay approach 56 Cost-effectiveness in Health and Medicine, 1996. ,
Productivity losses without absence: measurement validation and empirical evidence, Health Policy, vol.48, issue.1, pp.13-2731, 1999. ,
DOI : 10.1016/S0168-8510(99)00028-7
Clinical Signs and Symptoms Predicting Influenza Infection, Archives of Internal Medicine, vol.160, issue.21, pp.1351-1353, 2000. ,
DOI : 10.1001/archinte.160.21.3243
Influenza-Associated Morbidity and Mortality in Young and Middle-Aged Women, JAMA, vol.281, issue.10, pp.901-908, 1999. ,
DOI : 10.1001/jama.281.10.901
Patients' Utilities for Cancer Treatments: A Study of the Chained Procedure for the Standard Gamble and Time Tradeoff, Medical Decision Making, vol.18, issue.4, pp.391-400, 1998. ,
DOI : 10.1177/0272989X9801800406
Measuring the value of program outcomes: a review of multiattribute utility measures, Expert Review of Pharmacoeconomics & Outcomes Research, vol.1, issue.2, pp.215-243, 2001. ,
DOI : 10.1586/14737167.1.2.215
Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza, PharmacoEconomics, vol.16, issue.Supplement 1, pp.55-61, 1999. ,
DOI : 10.2165/00019053-199916001-00008
Willingness to pay for health risk reduction in the context of altruism, Health Economics, vol.23, issue.1, pp.623-658, 2002. ,
DOI : 10.1002/hec.687
Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.11, pp.834-876, 2000. ,
DOI : 10.1007/s100960000376
Antibiotic Prescribing for Adults With Colds, Upper Respiratory Tract Infections, and Bronchitis by Ambulatory Care Physicians, JAMA: The Journal of the American Medical Association, vol.278, issue.11, pp.901-905, 1997. ,
DOI : 10.1001/jama.1997.03550110039033
The Crisis in Antibiotic Resistance, Science, vol.257, issue.5073, pp.1064-73, 1992. ,
DOI : 10.1126/science.257.5073.1064
Epidemiology of Drug Resistance: Implications for a Post--Antimicrobial Era, Science, vol.257, issue.5073, pp.1050-1055, 1992. ,
DOI : 10.1126/science.257.5073.1050
Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods, Annals of Internal Medicine, vol.134, issue.6, pp.479-86, 2001. ,
DOI : 10.7326/0003-4819-134-6-200103200-00013
Principles of Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Tract Infections in Adults: Background, Annals of Internal Medicine, vol.134, issue.6, pp.490-494, 2001. ,
DOI : 10.7326/0003-4819-134-6-200103200-00015
Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation?, Health Economics, vol.5, issue.3, pp.217-2632, 1996. ,
DOI : 10.1002/(SICI)1099-1050(199605)5:3<217::AID-HEC200>3.0.CO;2-S
Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?, Health Economics, vol.78, issue.7, pp.637-684, 2002. ,
DOI : 10.1002/hec.693
Predictors of Influenza Vaccine Acceptance among Healthy Adults, Preventive Medicine, vol.29, issue.4, pp.249-62, 1999. ,
DOI : 10.1006/pmed.1999.0535
Interventions That Increase Use of Adult Immunization and Cancer Screening Services, Annals of Internal Medicine, vol.136, issue.9, pp.641-51, 2002. ,
DOI : 10.7326/0003-4819-136-9-200205070-00006
Changing the status of drugs from prescription to over-the-counter availability ,